Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pediatrics

Energy expenditure in obese children with pseudohypoparathyroidism type 1a

Abstract

Context:

Patients with pseudohypoparathyroidism type 1a (PHP-1a) develop early-onset obesity. The abnormality in energy expenditure and/or energy intake responsible for this weight gain is unknown.

Objective:

The aim of this study was to evaluate energy expenditure in children with PHP-1a compared with obese controls.

Patients:

We studied 6 obese females with PHP-1a and 17 obese female controls. Patients were recruited from a single academic center.

Measurements:

Resting energy expenditure (REE) and thermogenic effect of a high fat meal were measured using whole room indirect calorimetry. Body composition was assessed using whole body dual energy x-ray absorptiometry. Fasting glucose, insulin, and hemoglobin A1C were measured.

Results:

Children with PHP-1a had decreased REE compared with obese controls (P<0.01). After adjustment for fat-free mass, the PHP-1a group’s REE was 346.4 kcals day−1 less than obese controls (95% CI (−585.5–−106.9), P<0.01). The thermogenic effect of food (TEF), expressed as percent increase in postprandial energy expenditure over REE, was lower in PHP-1a patients than obese controls, but did not reach statistical significance (absolute reduction of 5.9%, 95% CI (−12.2–0.3%), P=0.06).

Conclusions:

Our data indicate that children with PHP-1a have decreased REE compared with the obese controls, and that may contribute to the development of obesity in these children. These patients may also have abnormal diet-induced thermogenesis in response to a high-fat meal. Understanding the causes of obesity in PHP-1a may allow for targeted nutritional or pharmacologic treatments in the future.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Long DN, McGuire S, Levine MA, Weinstein LS, Germain-Lee EL . Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J Clin Endocrinol Metab 2007; 92: 1073–1079.

    Article  CAS  Google Scholar 

  2. Chen M, Gavrilova O, Liu J, Xie T, Deng C, Nguyen AT et al. Alternative Gnas gene products have opposite effects on glucose and lipid metabolism. Proc Natl Acad Sci USA 2005; 102: 7386–7391.

    Article  CAS  Google Scholar 

  3. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O’Rahilly S . Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085–1095.

    Article  CAS  Google Scholar 

  4. Thearle MS, Muller YL, Hanson RL, Mullins M, Abdussamad M, Tran J et al. Greater impact of melanocortin-4 receptor deficiency on rates of growth and risk of type 2 diabetes mellitus during childhood compared with adulthood in Pima Indians. Diabetes 2011; Nov: 21.

    Google Scholar 

  5. Chen M, Wang J, Dickerson KE, Kelleher J, Xie T, Gupta D et al. Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation. Cell Metab 2009; 9: 548–555.

    Article  Google Scholar 

  6. Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD . The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000; 141: 3072–3079.

    Article  CAS  Google Scholar 

  7. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L . Central melanocortin receptors regulate insulin action. J Clin Invest 2001; 108: 1079–1085.

    Article  CAS  Google Scholar 

  8. Butler AA, Marks DL, Fan W, Kuhn CM, Bartolome M, Cone RD . Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat Neurosci 2001; 4: 605–611.

    Article  CAS  Google Scholar 

  9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

    Article  CAS  Google Scholar 

  10. Weir JB . New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109: 1–9.

    Article  Google Scholar 

  11. Molnar D, Jeges S, Erhardt E, Schutz Y . Measured and predicted resting metabolic rate in obese and nonobese adolescents. J Pediatr 1995; 127: 571–577.

    Article  CAS  Google Scholar 

  12. Hofsteenge GH, Chinapaw MJ, Delemarre-van de Waal HA, Weijs PJ . Validation of predictive equations for resting energy expenditure in obese adolescents. Am J Clin Nutr 2010; 91: 1244–1254.

    Article  CAS  Google Scholar 

  13. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG . Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377–381.

    Article  Google Scholar 

  14. Huber P . The behavior of maximum likelihood estimates under nonstandard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability 1967; I: 221–233.

    Google Scholar 

  15. Ong KK, Amin R, Dunger DB . Pseudohypoparathyroidism--another monogenic obesity syndrome. Clin Endocrinol (Oxf) 2000; 52: 389–391.

    Article  CAS  Google Scholar 

  16. Lomenick JP, El-Sayyid M, Smith WJ . Effect of levo-thyroxine treatment on weight and body mass index in children with acquired hypothyroidism. J Pediatr 2008; 152: 96–100.

    Article  CAS  Google Scholar 

  17. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360: 44–52.

    Article  CAS  Google Scholar 

  18. Nwosu BU, Lee MM . Pseudohypoparathyroidism type 1a and insulin resistance in a child. Nat Rev Endocrinol 2009; 5: 345–350.

    Article  Google Scholar 

  19. Dekelbab BH, Aughton DJ, Levine MA . Pseudohypoparathyroidism type 1A and morbid obesity in infancy. Endocr Pract 2009; 15: 249–253.

    Article  Google Scholar 

  20. Germain-Lee EL, Groman J, Crane JL, Jan de Beur SM, Levine MA . Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab 2003; 88: 4059–4069.

    Article  CAS  Google Scholar 

  21. Mantovani G, Maghnie M, Weber G, De Menis E, Brunelli V, Cappa M et al. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab 2003; 88: 4070–4074.

    Article  CAS  Google Scholar 

  22. Stenlof K, Sjostrom L, Lonn L, Bosaeus I, Kvist H, Tolli J et al. Effects of recombinant human growth hormone on basal metabolic rate in adults with pituitary deficiency. Metabolism 1995; 44: 67–74.

    Article  CAS  Google Scholar 

  23. Chong PK, Jung RT, Scrimgeour CM, Rennie MJ, Paterson CR . Energy expenditure and body composition in growth hormone deficient adults on exogenous growth hormone. Clin Endocrinol (Oxf) 1994; 40: 103–110.

    Article  CAS  Google Scholar 

  24. Karmisholt J, Andersen S, Laurberg P . Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxoedema. J Clin Endocrinol Metab 2011; 96: E99–103.

    Article  CAS  Google Scholar 

  25. Kong WM, Sheikh MH, Lumb PJ, Naoumova RP, Freedman DB, Crook M et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 2002; 112: 348–354.

    Article  CAS  Google Scholar 

  26. Krakoff J, Ma L, Kobes S, Knowler WC, Hanson RL, Bogardus C et al. Lower metabolic rate in individuals heterozygous for either a frameshift or a functional missense MC4R variant. Diabetes 2008; 57: 3267–3272.

    Article  CAS  Google Scholar 

  27. Schutz Y, Bessard T, Jequier E . Diet-induced thermogenesis measured over a whole day in obese and nonobese women. Am J Clin Nutr 1984; 40: 542–552.

    Article  CAS  Google Scholar 

  28. Camastra S, Bonora E, Del Prato S, Rett K, Weck M, Ferrannini E . Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord 1999; 23: 1307–1313.

    Article  CAS  Google Scholar 

  29. Segal KR, Albu J, Chun A, Edano A, Legaspi B, Pi-Sunyer FX . Independent effects of obesity and insulin resistance on postprandial thermogenesis in men. J Clin Invest 1992; 89: 824–833.

    Article  CAS  Google Scholar 

  30. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 271–279.

    Article  CAS  Google Scholar 

  31. Henry CJ, Lightowler HJ, Marchini J . Intra-individual variation in resting metabolic rate during the menstrual cycle. Br J Nutr 2003; 89: 811–817.

    Article  CAS  Google Scholar 

  32. Melanson KJ, Saltzman E, Russell R, Roberts SB . Postabsorptive and postprandial energy expenditure and substrate oxidation do not change during the menstrual cycle in young women. J Nutr 1996; 126: 2531–2538.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Rachel Lippert for her assistance with the mutation analysis and Lauren Whitaker for her assistance with the indirect calorimetry. We would like to acknowledge all the patients and their families who made this research possible. This study was supported in part by NIH grants 5T32HD060554-02 (AHS), the Vanderbilt CTSA grant URL1 RR024975-01 from NCRR/NIH, and 5 M01 RR-000095 from the NCRR/NIH (AHS), RO1DK070332 (RDC), and by a Fellows Development Research Grant in Diabetes, Obesity and Fat Cell Biology from the Endocrine Fellows Foundation (AHS).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A H Shoemaker.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shoemaker, A., Lomenick, J., Saville, B. et al. Energy expenditure in obese children with pseudohypoparathyroidism type 1a. Int J Obes 37, 1147–1153 (2013). https://doi.org/10.1038/ijo.2012.200

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2012.200

Keywords

This article is cited by

Search

Quick links